Leadership & Pay ·
On August 11, 2026, Ascendis Pharma A/S granted 15,060 warrants to certain employees under its Articles of Association
ASNDAscendis Pharma A/S
On August 11, 2026, Ascendis Pharma A/S granted 15,060 warrants to certain employees under its Articles of Association. Each warrant allows subscription for one ordinary share at an exercise price of $254.57, matching the closing stock price on the grant date. Vesting schedules dictate that 25% vest after one year, with the remaining 75% vesting monthly over three years contingent on continued service. Following this issuance, 1,524,443 warrants remain available for future grants. Ascendis Pharma A/S operates in the biotechnology industry, focusing on the development of therapies for rare diseases.